Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5VW1

Crystal structure of SpyCas9-sgRNA-AcrIIA4 ternary complex

Summary for 5VW1
Entry DOI10.2210/pdb5vw1/pdb
DescriptorCRISPR-associated endonuclease Cas9/Csn1, sgRNA, anti-CRISPR protein AcrIIA4, ... (8 entities in total)
Functional Keywordstype ii crispr-cas endonculease: cas9: structure: endonuclease: anti-crispr protein: inhibition of cas9: ruvc catalytic pocket: sequence-specific pam recognition: genome editing tool, hydrolase
Biological sourceStreptococcus pyogenes serotype M1
More
Total number of polymer chains3
Total formula weight197146.49
Authors
Yang, H.,Patel, D.J. (deposition date: 2017-05-21, release date: 2017-06-28, Last modification date: 2023-10-04)
Primary citationYang, H.,Patel, D.J.
Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Mol. Cell, 67:117-127.e5, 2017
Cited by
PubMed Abstract: Prokaryotic CRISPR-Cas adaptive immune systems utilize sequence-specific RNA-guided endonucleases to defend against infection by viruses, bacteriophages, and mobile elements, while these foreign genetic elements evolve diverse anti-CRISPR proteins to overcome the CRISPR-Cas-mediated defense of the host. Recently, AcrIIA2 and AcrIIA4, encoded by Listeria monocytogene prophages, were shown to block the endonuclease activity of type II-A Streptococcus pyogene Cas9 (SpyCas9). We now report the crystal structure of AcrIIA4 in complex with single-guide RNA-bound SpyCas9, thereby establishing that AcrIIA4 preferentially targets critical residues essential for PAM duplex recognition, as well as blocks target DNA access to key catalytic residues lining the RuvC pocket. These structural insights, validated by biochemical assays on key mutants, demonstrate that AcrIIA4 competitively occupies both PAM-interacting and non-target DNA strand cleavage catalytic pockets. Our studies provide insights into anti-CRISPR-mediated suppression mechanisms for inactivating SpyCas9, thereby broadening the applicability of CRISPR-Cas regulatory tools for genome editing.
PubMed: 28602637
DOI: 10.1016/j.molcel.2017.05.024
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.598 Å)
Structure validation

249524

PDB entries from 2026-02-18

PDB statisticsPDBj update infoContact PDBjnumon